Johan Rajander
Turku, 20520, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications
Intracranial Human BT12 Glioblastoma Xenograft is [18F]FET PET Negative but 6-[18F]Fluoronicotinic Acid PET Positive: Exploring a Novel Approach for Clinical Glioblastoma Imaging.
Journal: Molecular pharmaceutics
Published: June 09, 2026
Correction to: Exercise training partly ameliorates cardiac dysfunction in mice during doxorubicin treatment of breast cancer.
Journal: Journal of translational medicine
Published: June 02, 2026
TSPO-PET-measurable neuroinflammation associates with information processing speed decline in multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: May 31, 2026
Cerebral glucose utilisation during musical emotions: A multimodal functional PET/MRI study.
Journal: NeuroImage
Published: March 09, 2026
Association between post-COVID-19 neuropsychiatric symptoms and persistent glial activation in the limbic system: a TSPO PET study.
Journal: Journal of neurology
Published: February 18, 2026
Fluorine-18 Radiolabeled Single-Chain Antibody Variable Fragment 1F4 Targets α1-Subunit Gamma-Aminobutyric Acid Type A Receptors in Mice.
Journal: Journal of medicinal chemistry
Published: February 09, 2026
Change in brain glucose metabolism and cognition in amnestic MCI patients in relation to amyloid accumulation: A 3-year follow-up study.
Journal: Aging brain
Published: February 04, 2026
Correction: Longitudinal accumulation of glial activation measured by TSPO-PET predicts later brain atrophy in multiple sclerosis.
Journal: Journal of neuroinflammation
Published: February 03, 2026
Cannabidiol modulates brain molecular alterations, gut microbiota dysbiosis and alcohol self-administration in a mouse model of fetal alcohol spectrum disorder.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 07, 2025
Last Updated: 09/26/2026